arrow
L

Leonardo Pantoni

casa di cura igea
H指数:87
被引数:3.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond anticoagulation: Statin therapy and 90-day mortality after breakthrough ischemic stroke in atrial fibrillation

超越抗凝治疗:他汀类药物疗法与房颤患者突破性缺血性卒中后90天死亡率

2026-11-030
PRE
Haemorrhagic Transformation in Breakthrough Ischemic Stroke: Clinical Characteristics, Outcomes, and Anticoagulation Resumption Timing—Insights from the ASPERA-R Study

突破性缺血性卒中中的出血转化:临床特征、结局和抗凝恢复时机——ASPERA-R研究的启示

2026-11-030
PRE
Computed Tomography Perfusion in Suspected Ischemic Stroke: Patient-Related Pitfalls and Practical Clues Beyond Automated Interpretation

疑似缺血性卒中患者的CT灌注成像:患者相关陷阱及自动化解读之外的实用线索

2026-10-110
OAAI
Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis

心房颤动口服抗凝患者突破性缺血性卒中后,后循环与前循环梗死部位的比较及预后:一项ASPERA-R逆概率加权分析

2026-09-290
PRE
Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study

尽管正在接受口服抗凝治疗,仍发生缺血性卒中的病因解读及其临床影响:ASPERA-R研究

2026-08-170
OAAI
Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study

早期与晚期开始直接口服抗凝剂治疗突破性缺血性卒中:一项来自ASPERA-R研究的靶向试验分析

2026-06-190
PRE
Global burden of cerebral small vessel disease determined from large MRI studies: A systematic review and meta-analysis

全球小血管疾病负担的确定基于大规模MRI研究:一项系统综述和荟萃分析

2026-04-040
PRE
Italian intersocietal recommendations for restructuring the diagnostic-therapeutic pathway for the implementation and appropriate use of anti-amyloid monoclonal antibodies in Alzheimer’s disease

意大利跨学会关于重组阿尔茨海默病中抗淀粉样蛋白单克隆抗体实施与合理应用的诊断-治疗路径的建议

2025-10-170
OA
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment
2024-09-013
OAAI